Online GLP-1 Weight Support Program

MEDVi is an online telehealth platform that connects adults in the United States with licensed providers for a personalized weight management program centered around GLP-1 medications such as semaglutide and tirzepatide. The program begins with a brief health assessment, which helps determine eligibility and guide a tailored approach reviewed by medical professionals. The platform offers two main care options — weekly GLP-1 injections starting at an initial fee and daily oral GLP-1 tablets — with transparent pricing shared before enrollment. All medication and support services are delivered through partnered U.S. pharmacies, and the process is structured to be managed from home without the need for traditional clinic visits or insurance paperwork. MEDVi highlights features such as clear pricing, medication shipped to your door, and support from a care team, including licensed clinicians available for guidance throughout the program. Promotional materials shared on the site reference reported experiences from individuals who used the program, noting changes in body weight and lifestyle improvements while following a personalized care plan. The service emphasizes online convenience, ongoing clinical oversight, and a structured assessment of suitability for the program. Pricing typically starts at an introductory rate for the first month of treatment, followed by monthly fees for ongoing support and medication, without long-term contracts.

This website uses technologies such as cookies to enable essential website functionality, as well as for data analysis, personalization, and targeted advertising.